1. Home
  2. TLIH vs PLUR Comparison

TLIH vs PLUR Comparison

Compare TLIH & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$0.36

Market Cap

29.1M

Sector

N/A

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.36

Market Cap

34.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
PLUR
Founded
1998
2001
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
34.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TLIH
PLUR
Price
$0.36
$3.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
270.3K
58.1K
Earning Date
09-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$51,204,304.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$3.28
N/A
Revenue Growth
N/A
121.74
52 Week Low
$0.31
$3.20
52 Week High
$7.00
$7.13

Technical Indicators

Market Signals
Indicator
TLIH
PLUR
Relative Strength Index (RSI) N/A 39.82
Support Level N/A $3.20
Resistance Level N/A $3.94
Average True Range (ATR) 0.00 0.37
MACD 0.00 -0.02
Stochastic Oscillator 0.00 9.61

Price Performance

Historical Comparison
TLIH
PLUR

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: